Global Amifostine Market Growth 2026-2032
The global Amifostine market size is predicted to grow from US$ 501 million in 2025 to US$ 860 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2025, global Amifostine production reached approximately 4.68 M unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Amifostine Industry Forecast? looks at past sales and reviews total world Amifostine sales in 2025, providing a comprehensive analysis by region and market sector of projected Amifostine sales for 2026 through 2032. With Amifostine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amifostine industry.
This Insight Report provides a comprehensive analysis of the global Amifostine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amifostine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Amifostine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amifostine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amifostine.
This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Amifostine market?
What factors are driving Amifostine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amifostine market opportunities vary by end market size?
How does Amifostine break out by Type, by Application?
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2025, global Amifostine production reached approximately 4.68 M unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Amifostine Industry Forecast? looks at past sales and reviews total world Amifostine sales in 2025, providing a comprehensive analysis by region and market sector of projected Amifostine sales for 2026 through 2032. With Amifostine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amifostine industry.
This Insight Report provides a comprehensive analysis of the global Amifostine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amifostine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Amifostine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amifostine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amifostine.
This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 400mg/Dose
- 500mg/Dose
- Direct Sales
- Distribution
- Original Drug
- Generic Drug
- Advanced Ovarian Cancer
- Head and Neck Tumors
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Legacy Pharma / Ethyol
- Sun Pharma
- Taj Pharmaceuticals
- Luye Pharma
- Merro Pharmaceutical
- Kaifeng Mingren Pharma
- Shenzhen Zifu Pharma
- Sichuan Huiyu Pharma / Huiyu Haiyue
What is the 10-year outlook for the global Amifostine market?
What factors are driving Amifostine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amifostine market opportunities vary by end market size?
How does Amifostine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amifostine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Amifostine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Amifostine by Country/Region, 2021, 2025 & 2032
2.2 Amifostine Segment by Type
2.2.1 400mg/Dose
2.2.2 500mg/Dose
2.2.3 Amifostine Sales by Type
2.2.3.1 Global Amifostine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Amifostine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Amifostine Sale Price by Type (2021-2026)
2.3 Amifostine Segment by Channel
2.3.1 Direct Sales
2.3.2 Distribution
2.3.3 Amifostine Sales by Channel
2.3.3.1 Global Amifostine Sales Market Share by Channel (2021-2026)
2.3.3.2 Global Amifostine Revenue and Market Share by Channel (2021-2026)
2.3.3.3 Global Amifostine Sale Price by Channel (2021-2026)
2.4 Amifostine Segment by Technology
2.4.1 Original Drug
2.4.2 Generic Drug
2.4.3 Amifostine Sales by Technology
2.4.3.1 Global Amifostine Sales Market Share by Technology (2021-2026)
2.4.3.2 Global Amifostine Revenue and Market Share by Technology (2021-2026)
2.4.3.3 Global Amifostine Sale Price by Technology (2021-2026)
2.5 Amifostine Segment by Application
2.5.1 Advanced Ovarian Cancer
2.5.2 Head and Neck Tumors
2.5.3 Others
2.5.4 Amifostine Sales by Application
2.5.4.1 Global Amifostine Sale Market Share by Application (2021-2026)
2.5.4.2 Global Amifostine Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Amifostine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Amifostine Breakdown Data by Company
3.1.1 Global Amifostine Annual Sales by Company (2021-2026)
3.1.2 Global Amifostine Sales Market Share by Company (2021-2026)
3.2 Global Amifostine Annual Revenue by Company (2021-2026)
3.2.1 Global Amifostine Revenue by Company (2021-2026)
3.2.2 Global Amifostine Revenue Market Share by Company (2021-2026)
3.3 Global Amifostine Sale Price by Company
3.4 Key Manufacturers Amifostine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amifostine Product Location Distribution
3.4.2 Players Amifostine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMIFOSTINE BY GEOGRAPHIC REGION
4.1 World Historic Amifostine Market Size by Geographic Region (2021-2026)
4.1.1 Global Amifostine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Amifostine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Amifostine Market Size by Country/Region (2021-2026)
4.2.1 Global Amifostine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Amifostine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amifostine Sales Growth
4.4 APAC Amifostine Sales Growth
4.5 Europe Amifostine Sales Growth
4.6 Middle East & Africa Amifostine Sales Growth
5 AMERICAS
5.1 Americas Amifostine Sales by Country
5.1.1 Americas Amifostine Sales by Country (2021-2026)
5.1.2 Americas Amifostine Revenue by Country (2021-2026)
5.2 Americas Amifostine Sales by Type (2021-2026)
5.3 Americas Amifostine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amifostine Sales by Region
6.1.1 APAC Amifostine Sales by Region (2021-2026)
6.1.2 APAC Amifostine Revenue by Region (2021-2026)
6.2 APAC Amifostine Sales by Type (2021-2026)
6.3 APAC Amifostine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amifostine by Country
7.1.1 Europe Amifostine Sales by Country (2021-2026)
7.1.2 Europe Amifostine Revenue by Country (2021-2026)
7.2 Europe Amifostine Sales by Type (2021-2026)
7.3 Europe Amifostine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amifostine by Country
8.1.1 Middle East & Africa Amifostine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Amifostine Revenue by Country (2021-2026)
8.2 Middle East & Africa Amifostine Sales by Type (2021-2026)
8.3 Middle East & Africa Amifostine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amifostine
10.3 Manufacturing Process Analysis of Amifostine
10.4 Industry Chain Structure of Amifostine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amifostine Distributors
11.3 Amifostine Customer
12 WORLD FORECAST REVIEW FOR AMIFOSTINE BY GEOGRAPHIC REGION
12.1 Global Amifostine Market Size Forecast by Region
12.1.1 Global Amifostine Forecast by Region (2027-2032)
12.1.2 Global Amifostine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Amifostine Forecast by Type (2027-2032)
12.7 Global Amifostine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Legacy Pharma / Ethyol
13.1.1 Legacy Pharma / Ethyol Company Information
13.1.2 Legacy Pharma / Ethyol Amifostine Product Portfolios and Specifications
13.1.3 Legacy Pharma / Ethyol Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Legacy Pharma / Ethyol Main Business Overview
13.1.5 Legacy Pharma / Ethyol Latest Developments
13.2 Sun Pharma
13.2.1 Sun Pharma Company Information
13.2.2 Sun Pharma Amifostine Product Portfolios and Specifications
13.2.3 Sun Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sun Pharma Main Business Overview
13.2.5 Sun Pharma Latest Developments
13.3 Taj Pharmaceuticals
13.3.1 Taj Pharmaceuticals Company Information
13.3.2 Taj Pharmaceuticals Amifostine Product Portfolios and Specifications
13.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Taj Pharmaceuticals Main Business Overview
13.3.5 Taj Pharmaceuticals Latest Developments
13.4 Luye Pharma
13.4.1 Luye Pharma Company Information
13.4.2 Luye Pharma Amifostine Product Portfolios and Specifications
13.4.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Luye Pharma Main Business Overview
13.4.5 Luye Pharma Latest Developments
13.5 Merro Pharmaceutical
13.5.1 Merro Pharmaceutical Company Information
13.5.2 Merro Pharmaceutical Amifostine Product Portfolios and Specifications
13.5.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merro Pharmaceutical Main Business Overview
13.5.5 Merro Pharmaceutical Latest Developments
13.6 Kaifeng Mingren Pharma
13.6.1 Kaifeng Mingren Pharma Company Information
13.6.2 Kaifeng Mingren Pharma Amifostine Product Portfolios and Specifications
13.6.3 Kaifeng Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kaifeng Mingren Pharma Main Business Overview
13.6.5 Kaifeng Mingren Pharma Latest Developments
13.7 Shenzhen Zifu Pharma
13.7.1 Shenzhen Zifu Pharma Company Information
13.7.2 Shenzhen Zifu Pharma Amifostine Product Portfolios and Specifications
13.7.3 Shenzhen Zifu Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shenzhen Zifu Pharma Main Business Overview
13.7.5 Shenzhen Zifu Pharma Latest Developments
13.8 Sichuan Huiyu Pharma / Huiyu Haiyue
13.8.1 Sichuan Huiyu Pharma / Huiyu Haiyue Company Information
13.8.2 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Product Portfolios and Specifications
13.8.3 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sichuan Huiyu Pharma / Huiyu Haiyue Main Business Overview
13.8.5 Sichuan Huiyu Pharma / Huiyu Haiyue Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amifostine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Amifostine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Amifostine by Country/Region, 2021, 2025 & 2032
2.2 Amifostine Segment by Type
2.2.1 400mg/Dose
2.2.2 500mg/Dose
2.2.3 Amifostine Sales by Type
2.2.3.1 Global Amifostine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Amifostine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Amifostine Sale Price by Type (2021-2026)
2.3 Amifostine Segment by Channel
2.3.1 Direct Sales
2.3.2 Distribution
2.3.3 Amifostine Sales by Channel
2.3.3.1 Global Amifostine Sales Market Share by Channel (2021-2026)
2.3.3.2 Global Amifostine Revenue and Market Share by Channel (2021-2026)
2.3.3.3 Global Amifostine Sale Price by Channel (2021-2026)
2.4 Amifostine Segment by Technology
2.4.1 Original Drug
2.4.2 Generic Drug
2.4.3 Amifostine Sales by Technology
2.4.3.1 Global Amifostine Sales Market Share by Technology (2021-2026)
2.4.3.2 Global Amifostine Revenue and Market Share by Technology (2021-2026)
2.4.3.3 Global Amifostine Sale Price by Technology (2021-2026)
2.5 Amifostine Segment by Application
2.5.1 Advanced Ovarian Cancer
2.5.2 Head and Neck Tumors
2.5.3 Others
2.5.4 Amifostine Sales by Application
2.5.4.1 Global Amifostine Sale Market Share by Application (2021-2026)
2.5.4.2 Global Amifostine Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Amifostine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Amifostine Breakdown Data by Company
3.1.1 Global Amifostine Annual Sales by Company (2021-2026)
3.1.2 Global Amifostine Sales Market Share by Company (2021-2026)
3.2 Global Amifostine Annual Revenue by Company (2021-2026)
3.2.1 Global Amifostine Revenue by Company (2021-2026)
3.2.2 Global Amifostine Revenue Market Share by Company (2021-2026)
3.3 Global Amifostine Sale Price by Company
3.4 Key Manufacturers Amifostine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amifostine Product Location Distribution
3.4.2 Players Amifostine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMIFOSTINE BY GEOGRAPHIC REGION
4.1 World Historic Amifostine Market Size by Geographic Region (2021-2026)
4.1.1 Global Amifostine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Amifostine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Amifostine Market Size by Country/Region (2021-2026)
4.2.1 Global Amifostine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Amifostine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Amifostine Sales Growth
4.4 APAC Amifostine Sales Growth
4.5 Europe Amifostine Sales Growth
4.6 Middle East & Africa Amifostine Sales Growth
5 AMERICAS
5.1 Americas Amifostine Sales by Country
5.1.1 Americas Amifostine Sales by Country (2021-2026)
5.1.2 Americas Amifostine Revenue by Country (2021-2026)
5.2 Americas Amifostine Sales by Type (2021-2026)
5.3 Americas Amifostine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amifostine Sales by Region
6.1.1 APAC Amifostine Sales by Region (2021-2026)
6.1.2 APAC Amifostine Revenue by Region (2021-2026)
6.2 APAC Amifostine Sales by Type (2021-2026)
6.3 APAC Amifostine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amifostine by Country
7.1.1 Europe Amifostine Sales by Country (2021-2026)
7.1.2 Europe Amifostine Revenue by Country (2021-2026)
7.2 Europe Amifostine Sales by Type (2021-2026)
7.3 Europe Amifostine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amifostine by Country
8.1.1 Middle East & Africa Amifostine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Amifostine Revenue by Country (2021-2026)
8.2 Middle East & Africa Amifostine Sales by Type (2021-2026)
8.3 Middle East & Africa Amifostine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amifostine
10.3 Manufacturing Process Analysis of Amifostine
10.4 Industry Chain Structure of Amifostine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amifostine Distributors
11.3 Amifostine Customer
12 WORLD FORECAST REVIEW FOR AMIFOSTINE BY GEOGRAPHIC REGION
12.1 Global Amifostine Market Size Forecast by Region
12.1.1 Global Amifostine Forecast by Region (2027-2032)
12.1.2 Global Amifostine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Amifostine Forecast by Type (2027-2032)
12.7 Global Amifostine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Legacy Pharma / Ethyol
13.1.1 Legacy Pharma / Ethyol Company Information
13.1.2 Legacy Pharma / Ethyol Amifostine Product Portfolios and Specifications
13.1.3 Legacy Pharma / Ethyol Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Legacy Pharma / Ethyol Main Business Overview
13.1.5 Legacy Pharma / Ethyol Latest Developments
13.2 Sun Pharma
13.2.1 Sun Pharma Company Information
13.2.2 Sun Pharma Amifostine Product Portfolios and Specifications
13.2.3 Sun Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sun Pharma Main Business Overview
13.2.5 Sun Pharma Latest Developments
13.3 Taj Pharmaceuticals
13.3.1 Taj Pharmaceuticals Company Information
13.3.2 Taj Pharmaceuticals Amifostine Product Portfolios and Specifications
13.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Taj Pharmaceuticals Main Business Overview
13.3.5 Taj Pharmaceuticals Latest Developments
13.4 Luye Pharma
13.4.1 Luye Pharma Company Information
13.4.2 Luye Pharma Amifostine Product Portfolios and Specifications
13.4.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Luye Pharma Main Business Overview
13.4.5 Luye Pharma Latest Developments
13.5 Merro Pharmaceutical
13.5.1 Merro Pharmaceutical Company Information
13.5.2 Merro Pharmaceutical Amifostine Product Portfolios and Specifications
13.5.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Merro Pharmaceutical Main Business Overview
13.5.5 Merro Pharmaceutical Latest Developments
13.6 Kaifeng Mingren Pharma
13.6.1 Kaifeng Mingren Pharma Company Information
13.6.2 Kaifeng Mingren Pharma Amifostine Product Portfolios and Specifications
13.6.3 Kaifeng Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kaifeng Mingren Pharma Main Business Overview
13.6.5 Kaifeng Mingren Pharma Latest Developments
13.7 Shenzhen Zifu Pharma
13.7.1 Shenzhen Zifu Pharma Company Information
13.7.2 Shenzhen Zifu Pharma Amifostine Product Portfolios and Specifications
13.7.3 Shenzhen Zifu Pharma Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shenzhen Zifu Pharma Main Business Overview
13.7.5 Shenzhen Zifu Pharma Latest Developments
13.8 Sichuan Huiyu Pharma / Huiyu Haiyue
13.8.1 Sichuan Huiyu Pharma / Huiyu Haiyue Company Information
13.8.2 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Product Portfolios and Specifications
13.8.3 Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sichuan Huiyu Pharma / Huiyu Haiyue Main Business Overview
13.8.5 Sichuan Huiyu Pharma / Huiyu Haiyue Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amifostine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Amifostine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 400mg/Dose
Table 4. Major Players of 500mg/Dose
Table 5. Global Amifostine Sales by Type (2021-2026) & (K Units)
Table 6. Global Amifostine Sales Market Share by Type (2021-2026)
Table 7. Global Amifostine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Amifostine Revenue Market Share by Type (2021-2026)
Table 9. Global Amifostine Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Direct Sales
Table 11. Major Players of Distribution
Table 12. Global Amifostine Sales by Channel (2021-2026) & (K Units)
Table 13. Global Amifostine Sales Market Share by Channel (2021-2026)
Table 14. Global Amifostine Revenue by Channel (2021-2026) & ($ million)
Table 15. Global Amifostine Revenue Market Share by Channel (2021-2026)
Table 16. Global Amifostine Sale Price by Channel (2021-2026) & (USD/Unit)
Table 17. Major Players of Original Drug
Table 18. Major Players of Generic Drug
Table 19. Global Amifostine Sales by Technology (2021-2026) & (K Units)
Table 20. Global Amifostine Sales Market Share by Technology (2021-2026)
Table 21. Global Amifostine Revenue by Technology (2021-2026) & ($ million)
Table 22. Global Amifostine Revenue Market Share by Technology (2021-2026)
Table 23. Global Amifostine Sale Price by Technology (2021-2026) & (USD/Unit)
Table 24. Global Amifostine Sale by Application (2021-2026) & (K Units)
Table 25. Global Amifostine Sale Market Share by Application (2021-2026)
Table 26. Global Amifostine Revenue by Application (2021-2026) & ($ million)
Table 27. Global Amifostine Revenue Market Share by Application (2021-2026)
Table 28. Global Amifostine Sale Price by Application (2021-2026) & (USD/Unit)
Table 29. Global Amifostine Sales by Company (2021-2026) & (K Units)
Table 30. Global Amifostine Sales Market Share by Company (2021-2026)
Table 31. Global Amifostine Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Amifostine Revenue Market Share by Company (2021-2026)
Table 33. Global Amifostine Sale Price by Company (2021-2026) & (USD/Unit)
Table 34. Key Manufacturers Amifostine Producing Area Distribution and Sales Area
Table 35. Players Amifostine Products Offered
Table 36. Amifostine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Amifostine Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Amifostine Sales Market Share Geographic Region (2021-2026)
Table 41. Global Amifostine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Amifostine Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Amifostine Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Amifostine Sales Market Share by Country/Region (2021-2026)
Table 45. Global Amifostine Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Amifostine Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Amifostine Sales by Country (2021-2026) & (K Units)
Table 48. Americas Amifostine Sales Market Share by Country (2021-2026)
Table 49. Americas Amifostine Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Amifostine Sales by Type (2021-2026) & (K Units)
Table 51. Americas Amifostine Sales by Application (2021-2026) & (K Units)
Table 52. APAC Amifostine Sales by Region (2021-2026) & (K Units)
Table 53. APAC Amifostine Sales Market Share by Region (2021-2026)
Table 54. APAC Amifostine Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Amifostine Sales by Type (2021-2026) & (K Units)
Table 56. APAC Amifostine Sales by Application (2021-2026) & (K Units)
Table 57. Europe Amifostine Sales by Country (2021-2026) & (K Units)
Table 58. Europe Amifostine Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Amifostine Sales by Type (2021-2026) & (K Units)
Table 60. Europe Amifostine Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Amifostine Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Amifostine Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Amifostine Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Amifostine Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Amifostine
Table 66. Key Market Challenges & Risks of Amifostine
Table 67. Key Industry Trends of Amifostine
Table 68. Amifostine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Amifostine Distributors List
Table 71. Amifostine Customer List
Table 72. Global Amifostine Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Amifostine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Amifostine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Amifostine Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Amifostine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Amifostine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Amifostine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Amifostine Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Amifostine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Amifostine Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Amifostine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Legacy Pharma / Ethyol Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 87. Legacy Pharma / Ethyol Amifostine Product Portfolios and Specifications
Table 88. Legacy Pharma / Ethyol Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Legacy Pharma / Ethyol Main Business
Table 90. Legacy Pharma / Ethyol Latest Developments
Table 91. Sun Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 92. Sun Pharma Amifostine Product Portfolios and Specifications
Table 93. Sun Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 94. Sun Pharma Main Business
Table 95. Sun Pharma Latest Developments
Table 96. Taj Pharmaceuticals Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 97. Taj Pharmaceuticals Amifostine Product Portfolios and Specifications
Table 98. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 99. Taj Pharmaceuticals Main Business
Table 100. Taj Pharmaceuticals Latest Developments
Table 101. Luye Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 102. Luye Pharma Amifostine Product Portfolios and Specifications
Table 103. Luye Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 104. Luye Pharma Main Business
Table 105. Luye Pharma Latest Developments
Table 106. Merro Pharmaceutical Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 107. Merro Pharmaceutical Amifostine Product Portfolios and Specifications
Table 108. Merro Pharmaceutical Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 109. Merro Pharmaceutical Main Business
Table 110. Merro Pharmaceutical Latest Developments
Table 111. Kaifeng Mingren Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 112. Kaifeng Mingren Pharma Amifostine Product Portfolios and Specifications
Table 113. Kaifeng Mingren Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 114. Kaifeng Mingren Pharma Main Business
Table 115. Kaifeng Mingren Pharma Latest Developments
Table 116. Shenzhen Zifu Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 117. Shenzhen Zifu Pharma Amifostine Product Portfolios and Specifications
Table 118. Shenzhen Zifu Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 119. Shenzhen Zifu Pharma Main Business
Table 120. Shenzhen Zifu Pharma Latest Developments
Table 121. Sichuan Huiyu Pharma / Huiyu Haiyue Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 122. Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Product Portfolios and Specifications
Table 123. Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 124. Sichuan Huiyu Pharma / Huiyu Haiyue Main Business
Table 125. Sichuan Huiyu Pharma / Huiyu Haiyue Latest Developments
Table 1. Amifostine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Amifostine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 400mg/Dose
Table 4. Major Players of 500mg/Dose
Table 5. Global Amifostine Sales by Type (2021-2026) & (K Units)
Table 6. Global Amifostine Sales Market Share by Type (2021-2026)
Table 7. Global Amifostine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Amifostine Revenue Market Share by Type (2021-2026)
Table 9. Global Amifostine Sale Price by Type (2021-2026) & (USD/Unit)
Table 10. Major Players of Direct Sales
Table 11. Major Players of Distribution
Table 12. Global Amifostine Sales by Channel (2021-2026) & (K Units)
Table 13. Global Amifostine Sales Market Share by Channel (2021-2026)
Table 14. Global Amifostine Revenue by Channel (2021-2026) & ($ million)
Table 15. Global Amifostine Revenue Market Share by Channel (2021-2026)
Table 16. Global Amifostine Sale Price by Channel (2021-2026) & (USD/Unit)
Table 17. Major Players of Original Drug
Table 18. Major Players of Generic Drug
Table 19. Global Amifostine Sales by Technology (2021-2026) & (K Units)
Table 20. Global Amifostine Sales Market Share by Technology (2021-2026)
Table 21. Global Amifostine Revenue by Technology (2021-2026) & ($ million)
Table 22. Global Amifostine Revenue Market Share by Technology (2021-2026)
Table 23. Global Amifostine Sale Price by Technology (2021-2026) & (USD/Unit)
Table 24. Global Amifostine Sale by Application (2021-2026) & (K Units)
Table 25. Global Amifostine Sale Market Share by Application (2021-2026)
Table 26. Global Amifostine Revenue by Application (2021-2026) & ($ million)
Table 27. Global Amifostine Revenue Market Share by Application (2021-2026)
Table 28. Global Amifostine Sale Price by Application (2021-2026) & (USD/Unit)
Table 29. Global Amifostine Sales by Company (2021-2026) & (K Units)
Table 30. Global Amifostine Sales Market Share by Company (2021-2026)
Table 31. Global Amifostine Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Amifostine Revenue Market Share by Company (2021-2026)
Table 33. Global Amifostine Sale Price by Company (2021-2026) & (USD/Unit)
Table 34. Key Manufacturers Amifostine Producing Area Distribution and Sales Area
Table 35. Players Amifostine Products Offered
Table 36. Amifostine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Amifostine Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Amifostine Sales Market Share Geographic Region (2021-2026)
Table 41. Global Amifostine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Amifostine Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Amifostine Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Amifostine Sales Market Share by Country/Region (2021-2026)
Table 45. Global Amifostine Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Amifostine Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Amifostine Sales by Country (2021-2026) & (K Units)
Table 48. Americas Amifostine Sales Market Share by Country (2021-2026)
Table 49. Americas Amifostine Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Amifostine Sales by Type (2021-2026) & (K Units)
Table 51. Americas Amifostine Sales by Application (2021-2026) & (K Units)
Table 52. APAC Amifostine Sales by Region (2021-2026) & (K Units)
Table 53. APAC Amifostine Sales Market Share by Region (2021-2026)
Table 54. APAC Amifostine Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Amifostine Sales by Type (2021-2026) & (K Units)
Table 56. APAC Amifostine Sales by Application (2021-2026) & (K Units)
Table 57. Europe Amifostine Sales by Country (2021-2026) & (K Units)
Table 58. Europe Amifostine Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Amifostine Sales by Type (2021-2026) & (K Units)
Table 60. Europe Amifostine Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Amifostine Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Amifostine Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Amifostine Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Amifostine Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Amifostine
Table 66. Key Market Challenges & Risks of Amifostine
Table 67. Key Industry Trends of Amifostine
Table 68. Amifostine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Amifostine Distributors List
Table 71. Amifostine Customer List
Table 72. Global Amifostine Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Amifostine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Amifostine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Amifostine Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Amifostine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Amifostine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Amifostine Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Amifostine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Amifostine Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Amifostine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Amifostine Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Amifostine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Legacy Pharma / Ethyol Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 87. Legacy Pharma / Ethyol Amifostine Product Portfolios and Specifications
Table 88. Legacy Pharma / Ethyol Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Legacy Pharma / Ethyol Main Business
Table 90. Legacy Pharma / Ethyol Latest Developments
Table 91. Sun Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 92. Sun Pharma Amifostine Product Portfolios and Specifications
Table 93. Sun Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 94. Sun Pharma Main Business
Table 95. Sun Pharma Latest Developments
Table 96. Taj Pharmaceuticals Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 97. Taj Pharmaceuticals Amifostine Product Portfolios and Specifications
Table 98. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 99. Taj Pharmaceuticals Main Business
Table 100. Taj Pharmaceuticals Latest Developments
Table 101. Luye Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 102. Luye Pharma Amifostine Product Portfolios and Specifications
Table 103. Luye Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 104. Luye Pharma Main Business
Table 105. Luye Pharma Latest Developments
Table 106. Merro Pharmaceutical Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 107. Merro Pharmaceutical Amifostine Product Portfolios and Specifications
Table 108. Merro Pharmaceutical Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 109. Merro Pharmaceutical Main Business
Table 110. Merro Pharmaceutical Latest Developments
Table 111. Kaifeng Mingren Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 112. Kaifeng Mingren Pharma Amifostine Product Portfolios and Specifications
Table 113. Kaifeng Mingren Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 114. Kaifeng Mingren Pharma Main Business
Table 115. Kaifeng Mingren Pharma Latest Developments
Table 116. Shenzhen Zifu Pharma Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 117. Shenzhen Zifu Pharma Amifostine Product Portfolios and Specifications
Table 118. Shenzhen Zifu Pharma Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 119. Shenzhen Zifu Pharma Main Business
Table 120. Shenzhen Zifu Pharma Latest Developments
Table 121. Sichuan Huiyu Pharma / Huiyu Haiyue Basic Information, Amifostine Manufacturing Base, Sales Area and Its Competitors
Table 122. Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Product Portfolios and Specifications
Table 123. Sichuan Huiyu Pharma / Huiyu Haiyue Amifostine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 124. Sichuan Huiyu Pharma / Huiyu Haiyue Main Business
Table 125. Sichuan Huiyu Pharma / Huiyu Haiyue Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amifostine
Figure 2. Amifostine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amifostine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Amifostine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Amifostine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Amifostine Sales Market Share by Country/Region (2025)
Figure 10. Amifostine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 400mg/Dose
Figure 12. Product Picture of 500mg/Dose
Figure 13. Global Amifostine Sales Market Share by Type in 2026
Figure 14. Global Amifostine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Direct Sales
Figure 16. Product Picture of Distribution
Figure 17. Global Amifostine Sales Market Share by Channel in 2026
Figure 18. Global Amifostine Revenue Market Share by Channel (2021-2026)
Figure 19. Product Picture of Original Drug
Figure 20. Product Picture of Generic Drug
Figure 21. Global Amifostine Sales Market Share by Technology in 2026
Figure 22. Global Amifostine Revenue Market Share by Technology (2021-2026)
Figure 23. Amifostine Consumed in Advanced Ovarian Cancer
Figure 24. Global Amifostine Market: Advanced Ovarian Cancer (2021-2026) & (K Units)
Figure 25. Amifostine Consumed in Head and Neck Tumors
Figure 26. Global Amifostine Market: Head and Neck Tumors (2021-2026) & (K Units)
Figure 27. Amifostine Consumed in Others
Figure 28. Global Amifostine Market: Others (2021-2026) & (K Units)
Figure 29. Global Amifostine Sale Market Share by Application (2025)
Figure 30. Global Amifostine Revenue Market Share by Application in 2025
Figure 31. Amifostine Sales by Company in 2025 (K Units)
Figure 32. Global Amifostine Sales Market Share by Company in 2025
Figure 33. Amifostine Revenue by Company in 2025 ($ millions)
Figure 34. Global Amifostine Revenue Market Share by Company in 2025
Figure 35. Global Amifostine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Amifostine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Amifostine Sales 2021-2026 (K Units)
Figure 38. Americas Amifostine Revenue 2021-2026 ($ millions)
Figure 39. APAC Amifostine Sales 2021-2026 (K Units)
Figure 40. APAC Amifostine Revenue 2021-2026 ($ millions)
Figure 41. Europe Amifostine Sales 2021-2026 (K Units)
Figure 42. Europe Amifostine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Amifostine Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Amifostine Revenue 2021-2026 ($ millions)
Figure 45. Americas Amifostine Sales Market Share by Country in 2025
Figure 46. Americas Amifostine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Amifostine Sales Market Share by Type (2021-2026)
Figure 48. Americas Amifostine Sales Market Share by Application (2021-2026)
Figure 49. United States Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Amifostine Sales Market Share by Region in 2025
Figure 54. APAC Amifostine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Amifostine Sales Market Share by Type (2021-2026)
Figure 56. APAC Amifostine Sales Market Share by Application (2021-2026)
Figure 57. China Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Amifostine Sales Market Share by Country in 2025
Figure 65. Europe Amifostine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Amifostine Sales Market Share by Type (2021-2026)
Figure 67. Europe Amifostine Sales Market Share by Application (2021-2026)
Figure 68. Germany Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Amifostine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Amifostine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Amifostine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Amifostine in 2026
Figure 82. Manufacturing Process Analysis of Amifostine
Figure 83. Industry Chain Structure of Amifostine
Figure 84. Channels of Distribution
Figure 85. Global Amifostine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Amifostine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Amifostine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Amifostine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Amifostine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Amifostine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Amifostine
Figure 2. Amifostine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amifostine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Amifostine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Amifostine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Amifostine Sales Market Share by Country/Region (2025)
Figure 10. Amifostine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 400mg/Dose
Figure 12. Product Picture of 500mg/Dose
Figure 13. Global Amifostine Sales Market Share by Type in 2026
Figure 14. Global Amifostine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Direct Sales
Figure 16. Product Picture of Distribution
Figure 17. Global Amifostine Sales Market Share by Channel in 2026
Figure 18. Global Amifostine Revenue Market Share by Channel (2021-2026)
Figure 19. Product Picture of Original Drug
Figure 20. Product Picture of Generic Drug
Figure 21. Global Amifostine Sales Market Share by Technology in 2026
Figure 22. Global Amifostine Revenue Market Share by Technology (2021-2026)
Figure 23. Amifostine Consumed in Advanced Ovarian Cancer
Figure 24. Global Amifostine Market: Advanced Ovarian Cancer (2021-2026) & (K Units)
Figure 25. Amifostine Consumed in Head and Neck Tumors
Figure 26. Global Amifostine Market: Head and Neck Tumors (2021-2026) & (K Units)
Figure 27. Amifostine Consumed in Others
Figure 28. Global Amifostine Market: Others (2021-2026) & (K Units)
Figure 29. Global Amifostine Sale Market Share by Application (2025)
Figure 30. Global Amifostine Revenue Market Share by Application in 2025
Figure 31. Amifostine Sales by Company in 2025 (K Units)
Figure 32. Global Amifostine Sales Market Share by Company in 2025
Figure 33. Amifostine Revenue by Company in 2025 ($ millions)
Figure 34. Global Amifostine Revenue Market Share by Company in 2025
Figure 35. Global Amifostine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Amifostine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Amifostine Sales 2021-2026 (K Units)
Figure 38. Americas Amifostine Revenue 2021-2026 ($ millions)
Figure 39. APAC Amifostine Sales 2021-2026 (K Units)
Figure 40. APAC Amifostine Revenue 2021-2026 ($ millions)
Figure 41. Europe Amifostine Sales 2021-2026 (K Units)
Figure 42. Europe Amifostine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Amifostine Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Amifostine Revenue 2021-2026 ($ millions)
Figure 45. Americas Amifostine Sales Market Share by Country in 2025
Figure 46. Americas Amifostine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Amifostine Sales Market Share by Type (2021-2026)
Figure 48. Americas Amifostine Sales Market Share by Application (2021-2026)
Figure 49. United States Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Amifostine Sales Market Share by Region in 2025
Figure 54. APAC Amifostine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Amifostine Sales Market Share by Type (2021-2026)
Figure 56. APAC Amifostine Sales Market Share by Application (2021-2026)
Figure 57. China Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Amifostine Sales Market Share by Country in 2025
Figure 65. Europe Amifostine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Amifostine Sales Market Share by Type (2021-2026)
Figure 67. Europe Amifostine Sales Market Share by Application (2021-2026)
Figure 68. Germany Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Amifostine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Amifostine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Amifostine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Amifostine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Amifostine in 2026
Figure 82. Manufacturing Process Analysis of Amifostine
Figure 83. Industry Chain Structure of Amifostine
Figure 84. Channels of Distribution
Figure 85. Global Amifostine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Amifostine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Amifostine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Amifostine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Amifostine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Amifostine Revenue Market Share Forecast by Application (2027-2032)
